Open Access
| Issue |
BIO Web Conf.
Volume 240, 2026
The 2026 International Conference on Biomedicine, Neuroscience and Biostatistics (ICBNB 2026)
|
|
|---|---|---|
| Article Number | 01034 | |
| Number of page(s) | 7 | |
| Section | Biomedicine, Neuroscience and Biostatistics | |
| DOI | https://doi.org/10.1051/bioconf/202624001034 | |
| Published online | 24 June 2026 | |
- H. Sung, J. Ferlay, R. L. Siegel, M. Laversanne, I. Soerjomataram, A. Jemal, F. Bray, Global Cancer Statistics 2020: GLOBOCAN Estimates of Incidence and Mortality Worldwide for 36 Cancers in 185 Countries. CA: A Cancer Journal for Clinicians. 71, 3 (2021) [Google Scholar]
- D. Singh, J. Vignat, V. Lorenzoni, M. Eslahi, O. Ginsburg, B. Lauby-Secretan, F. Bray, S. Vaccarella, Global Estimates of Incidence and Mortality of Cervical Cancer in 2020: a Baseline Analysis of the WHO Global Cervical Cancer Elimination Initiative. The Lancet Global Health. 11, 2 (2022) [Google Scholar]
- R. U. Hakim, T. Amin, S.M.B. Islam, Advances and Challenges in Cervical Cancer: From Molecular Mechanisms and Global Epidemiology to Innovative Therapies and Prevention Strategies. Cancer Control. 3, 2 (2025) [Google Scholar]
- World Health Organization. Human papillomavirus vaccines: WHO position paper. (2022, December 16) Www.who.int. https://www.who.int/publications/i/item/who-wer9750-645-672 [Google Scholar]
- M. Felsher, M. Fisher-Borne, T. Malik, N. Santpurkar, S. Martin, O. Zaidi, W. Wang, C. Palmer, Cost-effectiveness modeling for gender-neutral human papillomavirus vaccines: A systematic literature review. Human Vaccines & Immunotherapeutics. 21, 1 (2025) [Google Scholar]
- M. Sultanov, G. H. de Bock, J. A. R. Koot, J. de Zeeuw, M. J. W. Greuter, F. Pan, J. Stekelenburg, J. J. Beltman, J. van der Schans, High-risk human papillomavirus testing for underscreened populations: cost-effectiveness and affordability in three country settings. BMC Public Health. 25, 1 (2025) [Google Scholar]
- S. P. Mongan, J. Byrnes, H. Kim, The Cost-Effectiveness of the Human Papilloma Virus Vaccination in Asia Pacific Countries: What Lessons Can Indonesia Learn?—A Systematic Review. Vaccines. 13, 6 (2025) [Google Scholar]
- H. S. Whitworth, K. E. Gallagher, N. Howard, S. Mounier-Jack, G. Mbwanji, D. Watson-Jones, Efficacy and immunogenicity of a single dose of human papillomavirus vaccine compared to no vaccination or standard three and two-dose vaccination regimens: A systematic review of evidence from clinical trials. Vaccine. 38, 6 (2020) [Google Scholar]
- Y. Huang, D. Zhang, L. Yin, J. Zhao, Z. Li, W. Wu, Modeling the Health Impact and Cost-Effectiveness of a Combined Schoolgirl HPV Vaccination and Cervical Cancer Screening Program in Guangdong Province, China. Children. 11, 1 (2024) [Google Scholar]
- D. M. Harper, L. R. DeMars, HPV vaccines – A review of the first decade. Gynecologic Oncology. 146, 1 (2017) [Google Scholar]
- C. J. Murray, Quantifying the burden of disease: the technical basis for disability-adjusted life years. Bulletin of the World Health Organization. 72, 3 (1994) [Google Scholar]
- Z. Zou, C. K. Fairley, J. J. Ong, J. Hocking, K. Canfell, X. Ma, E. P. F. Chow, X. Xu, L. Zhang, G. Zhuang, Domestic HPV vaccine price and economic returns for cervical cancer prevention in China: a cost-effectiveness analysis. The Lancet Global Health. 8, 10 (2020) [Google Scholar]
Current usage metrics show cumulative count of Article Views (full-text article views including HTML views, PDF and ePub downloads, according to the available data) and Abstracts Views on Vision4Press platform.
Data correspond to usage on the plateform after 2015. The current usage metrics is available 48-96 hours after online publication and is updated daily on week days.
Initial download of the metrics may take a while.